What question did this study set out to answer?

The study aims to investigate the impact of RAGE inhibitors on cerebral edema following glioma resection.

March 21, 2026NeurosurgeryOpen Access

RAGE Inhibition Reduces Surgery-Induced Cerebral Edema After Glioma Resection

View Full Paper

Ask AI

Bookmark

Authors

Evaluates RAGE inhibitors to reduce cerebral edema in murine glioma models, suggesting a steroid-sparing strategy for management.

The study aims to investigate the impact of RAGE inhibitors on cerebral edema following glioma resection.
Mice with CT-2A gliomas were randomized into four treatment groups: TTP488, FPS-ZM1, dexamethasone, or vehicle.
Perioperative treatments were administered from four days before surgery to seven days after tumor resection.
Cerebral edema was assessed using serial brain MRI and quantified with manual segmentation.
Neurological function and response to anti-PD-1 immunotherapy were evaluated alongside bulk RNA sequencing for gene expression analysis.
Cerebral edema peaked on postoperative day 2 but subsided by day 7 across all groups.
Both RAGE inhibitors significantly reduced edema on postoperative day 1 compared to the vehicle group (P = .03 for both).
Neither RAGE inhibitor impaired the efficacy of anti-PD-1 immunotherapy, unlike dexamethasone.
FPS-ZM1 also improved neurological recovery and wound healing, enhancing anti-PD-1 therapy at higher doses.

Dayyani et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

March 21, 2026NeurosurgeryOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Evaluates RAGE inhibitors to reduce cerebral edema in murine glioma models, suggesting a steroid-sparing strategy for management.

The study aims to investigate the impact of RAGE inhibitors on cerebral edema following glioma resection.
Mice with CT-2A gliomas were randomized into four treatment groups: TTP488, FPS-ZM1, dexamethasone, or vehicle.
Perioperative treatments were administered from four days before surgery to seven days after tumor resection.
Cerebral edema was assessed using serial brain MRI and quantified with manual segmentation.
Neurological function and response to anti-PD-1 immunotherapy were evaluated alongside bulk RNA sequencing for gene expression analysis.
Cerebral edema peaked on postoperative day 2 but subsided by day 7 across all groups.
Both RAGE inhibitors significantly reduced edema on postoperative day 1 compared to the vehicle group (P = .03 for both).
Neither RAGE inhibitor impaired the efficacy of anti-PD-1 immunotherapy, unlike dexamethasone.
FPS-ZM1 also improved neurological recovery and wound healing, enhancing anti-PD-1 therapy at higher doses.

Dayyani et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark